Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity.
Episode 15 with Professor Ludwig Kappos on the DECIDE trial of daclizumab versus interferon ë_-1a
Validation of the Brazilian version of the neurological fatigue index for multiple sclerosis.
195 How Well Do Neuroradiologists Predict the Side of Trigeminal Neuralgia?
Episode 21 with Dr. Paul Matthews discussing imaging in MS
Episode 33 with Dr. Pierre-Antoine Gourraud on the role of human leukocyte antigen in MS
Activity-Dependent and Experience-Driven Myelination Provide New Directions for the Management of Multiple Sclerosis.
The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
ForuMS: A Virtual Journal Club for MS Clinicians
Biogen Idec receives notification of PDUFA date extension
Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis.
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study.
Genzyme’s once-daily, oral AUBAGIO® (teriflunomide) approved in Argentina for the treatment of relapsing multiple sclerosis
Phase IV, Rater-blinded, Randomized Study, Comparing the Effects of 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-dose Gadolinium
Qiagen Webinar: Molecular Mechanisms of Neurodegeneration
Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis.
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).
A Combination Trial of Copaxone plus Estriol in Relapsing Remitting Multiple Sclerosis
Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: A systematic review and meta-analysis.
Long-term efficacy and safety of transanal irrigation in multiple sclerosis.
Interferon beta 1a anaphylaxis, a case report. Standardization of non-irritating concentration for allergy skin.
Keystone Symposium on the Gut Microbiome: The Effector/Regulatory Immune Network
Genes associated with T helper 17 cell differentiation and function.
FOCIS: Advanced Course in Basic & Clinical Immunology
Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.

Pages